Reshma Kewalramani |
CEO & President, Director |
$62.5M |
-$30.6M |
-32.8% |
Feb 12, 2025 |
Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$35.7M |
-$4.43M |
-11% |
Feb 12, 2025 |
Stuart A. Arbuckle |
Evp, Coo |
$35.7M |
-$5.71M |
-13.8% |
Feb 12, 2025 |
Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$31.7M |
-$3.68M |
-10.4% |
Feb 12, 2025 |
Charles F. Wagner Jr |
EVP & Chief Financial Officer |
$29.5M |
-$4.53M |
-13.3% |
Feb 12, 2025 |
Bruce I. Sachs |
Director |
$26.7M |
-$5.86M |
-18% |
Jan 15, 2025 |
David Altshuler |
EVP, Chief Scientific Officer |
$22.3M |
-$4.79M |
-17.7% |
Feb 12, 2025 |
Carmen Bozic |
EVP and CMO |
$19.7M |
-$6.49M |
-24.8% |
Feb 12, 2025 |
Jeffrey M. Leiden |
Executive Chairman, Director |
$13.8M |
-$1.89M |
-12.1% |
Feb 12, 2025 |
Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$13.5M |
-$5.51M |
-28.9% |
Feb 12, 2025 |
Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13.4M |
|
|
May 5, 2023 |
Jonathan Biller |
EVP and Chief Legal Officer |
$9.55M |
-$2.04M |
-17.6% |
Feb 12, 2025 |
Kristen Ambrose |
SVP & Chief Accounting Officer |
$5.53M |
-$1.11M |
-16.7% |
Feb 12, 2025 |
Joy Liu |
SVP, General Counsel |
$4.03M |
|
|
Aug 15, 2022 |
Diana Mckenzie |
Director |
$3.48M |
|
|
May 1, 2024 |
Terrence C. Kearney |
Director |
$3M |
|
|
May 1, 2024 |
Lloyd Carney |
Director |
$2.55M |
|
|
May 1, 2024 |
Sangeeta N. Bhatia |
Director |
$2.22M |
-$1.11M |
-33.4% |
Aug 30, 2024 |
Suketu Upadhyay |
Director |
$1.6M |
|
|
May 1, 2024 |
Nancy Thornberry |
Director |
$788K |
|
|
May 1, 2024 |
Michel Lagarde |
Director |
$731K |
|
|
May 1, 2024 |
Jennifer Schneider |
Director |
$372K |
|
|
May 15, 2024 |
Yuchun Lee |
Director |
$284K |
|
|
May 1, 2023 |
Margaret G. Mcglynn |
Director |
$284K |
|
|
May 1, 2023 |
Alan M. Garber |
Director |
$256K |
|
|
May 1, 2024 |